We present analyses relating cigarette type to lung cancer based on a case-control study in five European countries. The analyses involved 3561 cases and 2301 controls with diseases not associated with smoking. Subjects completed a detailed questionnaire, including a lifetime smoking history. Analyses included never smokers, and those who smoked for at least 80% of the "critical period" from 2 to 20 years before diagnosis, ignoring those who ever smoked pipes or cigars, or chewed tobacco. The main analysis compares risk in those who, in the critical period, smoked ultra-low tar (ULT) cigarettes (machine yield 3 mg tar/cigarette) for 8 þ years, with those who only smoked full flavour (FF) cigarettes (10 mg tar/ cigarette). After adjustment for sex, age, country, education, age of starting smoking, mean cigarette consumption and mean tar level 21e50 years before interview, the odds ratio (OR) was 0.73 (95% confidence interval (CI) 0.50e1.06). Other analyses showed a modest, not statistically significant, reduction in risk with tar reduction. Risk in ULT smokers for 8 þ years was substantially higher than in never smokers (OR 16.27, 95% CI 10.14e26.09). The study was prematurely terminated due to cost overrun, limiting the power to detect an association. More evidence is needed, particularly on lifetime ULT smoking.
Introduction
It has been known for many years that cigarette smoking causes lung cancer, and that the risk rises with increasing number of cigarettes smoked per day and with increasing duration of smoking (International Agency for Research on Cancer, 2004; Lee et al., 2012; US Surgeon General, 2014) . The observed dose-response relationship of daily amount smoked to risk of lung cancer led to the suggestion (Wynder, 1957; Wynder et al., 1957 ) that more effective filtration could be one of a number of measures that might reduce the risk. Since then cigarettes on the market have changed from being predominantly plain to predominantly filter, and tar levels per cigarette have massively reduced (Forey et al., 2006e2016; US Surgeon General, 2014) .
Whether this has actually helped to reduce lung cancer risk has been under discussion for many years. It has been pointed out (National Cancer Institute, 2001; US Surgeon General, 2014 ) that smokers switching to cigarettes with a lower tar or nicotine delivery as measured by smoking machines may, in an attempt to maintain their nicotine dose, "compensate" by smoking cigarettes more intensively and/or increasing the number of cigarettes smoked per day. However, a detailed investigation of the evidence suggests that though these forms of compensation may substantially reduce the benefit of switching to lower tar products, they do not eliminate it.
That there appears to be some benefit of switching to lower nicotine yield products can be demonstrated in various ways. Firstly, using an index in which 1 indicates complete compensation and 0 no compensation, Scherer and Lee (2014) combined evidence from 19 brand-switching studies to give an overall estimate of the compensation index of 0.781 (95% confidence interval [CI] 0.720 to 0.842). Based on this formula, a smoker switching to a cigarette with a 25% lower nicotine yield, as measured under standard smoking conditions, would, as a result of the considerable degree of compensation, only expect to be exposed to a 6% lower nicotine dose. Similarly, switching to a cigarette with a 50% lower machine yield, would only lead to a 14% decrease in dose.
Second, various reviews of the epidemiological evidence (Kabat, 2003; Lee, 2001; Lee et al., 2012; Lee and Sanders, 2004) have demonstrated a reduction in risk of lung cancer in smokers of filter compared to plain cigarettes and in smokers of lower tar compared to higher tar cigarettes. The latest of these reviews (Lee et al., 2012) , reported a 31% reduction in risk (95% CI 22%e39%) in "only filter" vs "only plain" cigarette smokers, with a 30% reduction in risk (95% CI 15%e42%) comparing smokers in the lowest vs highest tar groups. As also noted in an earlier review (Lee and Sanders, 2004 ) the benefit of reduction in yields was evident regardless of whether estimates were adjusted for daily cigarette consumption. Whether or not estimates should be adjusted is not in fact totally clear. Thus, if increased consumption is an effect of the reduction in nicotine yield, to do so might be considered over-adjustment (National Cancer Institute, 2001 ); however, if lighter smokers tend to be more likely to switch to lower yield cigarettes, not to do so might be considered under-adjustment.
While the latest review (Lee et al., 2012) was limited to studies published in the 1990s, a number of subsequent studies have tended to confirm the reduction in lung cancer risk associated with reduction in yields (Agudo et al., 2000; Brooks et al., 2003; de Stefani et al., 2002; Harris, 2004; Marugame et al., 2004; Papadopoulos et al., 2011; Simonato et al., 2001; Woodward, 2001) , the only exceptions being where estimates have a wide 95% confidence interval (Blizzard and Dwyer, 2003; Rachtan, 2002) .
Although the epidemiological evidence appears to confirm a reduction in lung cancer risk, it is subject to various limitations. Thus: (a) much of the evidence relates to comparison of smokers who have used reduced yield cigarettes for only a moderate proportion of their smoking lifetime; (b) some studies base results only on the brand smoked at one point in time or over a limited period; (c) lifetime histories are subject to errors in recall, particularly when respondents cannot recall brand names; and (d), as indicated above, it is difficult to make precise adjustment for those aspects of smoking which may be affected by a switch in the product smoked. One would really like to adjust for smoking habits measured preswitch, but this is rarely if ever done.
A major problem with the evidence is that much of it relates to cigarettes with tar yields that are not currently on the market, and which may not be relevant to cigarettes with tar yields of less than 10 mg tar. Notably, none of the evidence on risk relates to the smoking of ultra-low tar (ULT) cigarettes, cigarettes which are defined as having a machine yield of 3 mg or less tar per cigarette. ULT cigarettes have become increasingly popular in the last 30 years.
The objective of this paper is to present results from a casecontrol study which was principally aimed at comparing lung cancer risk from smoking ULT cigarettes with that from smoking full flavour (FF) cigarettes, cigarettes with a machine yield of at least 10 mg tar. However, some other results, including those relating to smoking low tar (LT) cigarettes with a machine yield intermediate between ULT and FF cigarettes, are also presented. This study, sponsored by Philip Morris International, was originally aimed at recruiting 13,000 cases and 13,000 controls, the large number of subjects being necessitated by the relatively low uptake of ULT cigarettes. Subject recruitment was initiated in December 2005, and continued until the sponsor discontinued support in October 2008 due to a substantial cost overrun. Though, at that time, detailed data were only available for about 30% of the planned sample, the numbers of cases and controls for which information was collected still make it one of the largest lung cancer case-control studies ever conducted.
Though a report on this study has already been made publicly available on the Philip Morris International website (Weinberg, 2013 ; provided as Supplementary File 1), this only presents results which relate average tar yield to lung cancer risk. While that report concluded that "average cigarette tar yield is an independent risk factor for lung cancer above and beyond the effects of smoking duration and smoking intensity", no results specifically relating ULT cigarette smoking to lung cancer risk were presented. Though we recognize that the premature termination of the study affects the precision of the risk estimates for ULT cigarette use, we feel it important to present the results relating to the original objective.
Materials and methods

Study design
As the methods by which the case-control study was conducted have been described earlier (see Supplementary File 1) , only a summary of these is given below.
The study was conducted in France, Germany, Greece, Italy and Slovenia, countries selected because market penetration of ULT prior to the study launch was relatively high. The study involved recently diagnosed, medically confirmed primary lung cancer and controls with an admission diagnosis not associated with smoking. Histological type of lung cancer was not routinely recorded. Though the study design involved individual matching of controls to cases by age (±5 years), sex and area of residence, the early study termination meant that pairing was often incomplete, so the data were analysed as if unpaired. All subjects considered signed the informed consent form, had a score of 18 or above on the Standardized Mini-Mental State Examination (Vertesi et al., 2001) , and completed a specifically designed Life Event History Calendar questionnaire, a data collection instrument that provided a framework of important events from the subject's own life history to aid the subjects' recall of past smoking habits (Belli, 1998; Belli et al., 2001 ). The smoking data included information on the number and brand of cigarettes smoked each year from the first year in which at least 100 cigarettes were smoked until 24e36 months prior to the date of signing the informed consent. Exclusion of recent smoking data sought to limit problems arising from smokers quitting or changing brands because they were ill prior to the lung cancer diagnosis. For each brand, tar yields were extracted from a Philip Morris database providing data from 1979. For earlier years, tar yields of 13 mg per cigarette were imputed. Missing data on amount smoked, and tar yield were imputed as described elsewhere in Supplementary File 1. The questionnaire also collected information on a range of demographic variables and exposure to other lung cancer risk factors.
At each time point it was possible to calculate from the smoking histories whether a subject then smoked and, if so, how many of each type of cigarette (ULT, LT or FF) were smoked, and hence the percentage smoked by type. If the percentage for any one type was greater than or equal to 70% the subject was declared to be a smoker of that type of cigarette in that year. If no type was smoked for at least 70% in the year they were declared to be a mixed cigarette smoker in that year.
Analysis
Analyses concentrated on the effects on lung cancer risk of smoking during the "critical period" from 2 to 20 years before diagnosis, as sales of ULT cigarettes before that period were negligible or non-existent in all the five countries involved. Never smokers were excluded from all analyses except those specifically involving never smokers. All analyses ignored smoking habits recorded in the year before diagnosis. Excluded from all analyses were those who had ever smoked cigars or pipes or chewed tobacco, those who had smoked for less than 80% of the "critical period" from 2 to 20 years before diagnosis, and the very few subjects who were mixed cigarette smokers throughout the critical period.
Various comparisons of risk in smokers were made:
1) (The pre-defined principal analysis). Those who had smoked ULT cigarettes for 8 or more years in the critical period were compared with those who had never smoked cigarettes other than FF (FF only smokers). 2) Those who had ever smoked ULT in the critical period were compared with those who had never smoked ULT cigarettes. 3) Those who had smoked ULT cigarettes for <8, 8e14 or 15 þ years in the critical period were compared with FF only smokers. 4) Those who had smoked LT or ULT cigarettes for <8, 8e14 or 15 þ years in the critical period were compared with FF only smokers. 5) Smokers with a mean tar level in the critical period of 13e13.49, 13.5e14.99 or 15 þ mg/cig were compared with smokers with a mean tar level of 12 mg/cig or less.
An additional comparison was made: 6) Those who had smoked ULT cigarettes for 8 or more years in the critical period were compared with those who had never smoked at all.
Logistic regression analyses estimated the odds ratio (and 95% CI) unadjusted for any variable, adjusted for single factors, or adjusted for all factors simultaneously. In analyses 3 to 5, tests of trend were also made, treating the successive levels as coded 0, 1, 2, etc. For comparison 6 the set of factors considered included sex (male, female), age at interview (55, 56e63, 64e70, 71 þ years), country (France, Germany, Greece, Italy, Slovenia), and education (none, primary, lower secondary, upper secondary, post secondary but non-tertiary, first or second stage tertiary, and not known). For comparisons 1 to 5 the set of factors also adjusted for age of initiating smoking (15, 16e19, 20 þ years), mean number of cigarettes smoked 21e50 years before interview (<15, 15e19, 20e29, 30þ, did not smoke at that time), and mean tar content 21e50 years before interview (<13, 13e13.49, 13.5e14.99, 15 þ mg/cig, did not smoke at that time). The period 21e50 years before interview was chosen as more recent smoking habits may be affected by ULT use. Adjustment for numbers of cigarettes smoked in the critical period was not attempted as this may lead to "over-adjustment" if reductions in tar yield lead to some increase in numbers smoked. Table 1 shows the distribution of the cases and controls by smoking habits overall, and by the various adjustment variables considered. The analyses conducted were based on a total of 3221 cases and 941 controls who had smoked, and on 340 cases and 1360 controls who had never smoked, the clear difference in the relative frequency of cases to controls in smokers (3.42e1) and never smokers (1e4) reflecting the strong effect of smoking on lung cancer risk.
Results
Among the 4162 subjects who smoked, there were 3201 (76.9%) males and 961 (23.1%) females, with 1710 (41.1%) from Germany, 1147 (27.6%) from Greece, 635 (15.3%) from Slovenia, 460 (11.1%) from France and 210 (5.0%) from Italy. 1679 (40.3%) had an education level of upper secondary or above. In contrast, among the 1700 subjects who had never smoked, the proportion of males (879 ¼ 51.7%) was markedly lower, and the proportion in the higher education level (810 ¼ 47.6%) was somewhat higher, and the relative frequency of subjects in the different countries also varied (Germany 809 ¼ 47.6%, Greece 225 ¼ 13.2%, Slovenia 356 ¼ 20.9%, France 247 ¼ 14.5% and Italy 63 ¼ 3.7%). Table 1 compares the distribution of the cases and controls by the five smoking groups considered (FF only, ULT <8 years, ULT 8e14 years, ULT 15 þ years and other smokers). Overall there was a slight excess of FF only smokers in cases compared to controls (59.0% vs 54.5%) and a slight deficiency of other smokers (33.3% vs 37.8%) with the proportion of ULT smokers quite similar. While this pattern was also evident in both sexes, it was notable that in both cases and controls, the proportion of ULT smokers was higher, and the proportion of FF only smokers was lower in females. There was no very marked variation in the distribution of age of starting to smoke and amount smoked between the five smoking groups, either in cases or controls. Table 2 shows the unadjusted and adjusted odds ratios (and 95% CIs) for the various analyses conducted. Based on the adjusted results, those who had used ULT cigarettes for eight or more years in the critical period had a non-significantly reduced risk of lung cancer (OR ¼ 0.73, 95% CI 0.50e1.06) compared to those who had used FF throughout the critical period. This was the pre-defined principal analysis. All the other analyses were also consistent with a modest role of tar reduction in reducing the risk of lung cancer. Thus, risk was somewhat reduced in those who had ever smoked ULT cigarettes compared to those who had never used them (OR ¼ 0.94, 95% CI 0.55e1.63), and for those who had smoked ULT cigarettes for <8, 8e14 or 15 þ years compared to those who smoked FF only. Risk was also reduced in those who had used ULT and/or LT compared to those who had smoked FF only, and increased with increasing level of mean tar level of cigarettes smoked. However, with the exception of evidence of a significant (p ¼ 0.02) dose-related trend in relation to duration of ULT and/or LT, the odds ratios cited were not clearly significant. In contrast, however, risk compared to that in never smokers, was clearly markedly increased in those who had used ULT for eight or more years in the critical period (OR ¼ 16.27, 95% CI 10.14e26.09).
Discussion
There are considerable difficulties in assessing the extent to which reductions in nicotine and tar yield have led to a reduction in risk of lung cancer. These include the following:
Compensation It has been estimated (Scherer and Lee, 2014 ) that a 50% reduction in machine nicotine yield might only produce a 14% reduction in the dose of nicotine (or tar) to the smoker, so making reductions in lung cancer risk more difficult to demonstrate epidemiologically.
Confounding Smokers choosing to use, or switch to, reduced yield products may differ from other smokers in various ways that are relevant to lung cancer risk. In this context, it is important to avoid over-adjustment, if, for example, switchers to reduced tar products tend to increase daily consumption as a consequence.
Inaccuracy in smoking histories When comparing smokers switching or not switching to lower yield products, it is important to adjust for smoking habits before the switch. Inaccuracies in determining smoking histories may affect the accuracy of such adjustment.
Narrow range of tar yields being compared Although some cigarettes may, in the past, have had tar yields exceeding 30 mg per cigarette, and although some cigarettes currently have tar yields less than 3 mg per cigarette, there has never been a time at which substantial groups of smokers smoked cigarettes with a very wide range of yields. This is partly because legislation has limited the sale of cigarettes with a very high tar yield, and partly because sales of ULT cigarettes have been very low.
Although the literature on cigarette type and lung cancer has, as noted in the introduction, demonstrated some reduction in lung cancer risk associated with the switch to filter cigarettes and with reduction in tar yields, many of the results relate to tar yields no longer relevant to current cigarettes, none relates to ULT cigarettes, and virtually none to LT cigarettes.
The purpose of the case-control study described here was to rectify this omission by allowing comparison of smokers of ULT and FF cigarettes, recognizing that this would be made more difficult by the relatively small proportion of smokers who use ULT cigarettes.
The study also sought to obtain detailed smoking histories from each subject by using a specially designed questionnaire, as summarized in the materials and methods section. This allowed us to carry out analyses in which we compared smokers of different cigarettes in the critical period (2e20 years before diagnosis), while adjusting for mean cigarette consumption and mean tar content during the period 21e50 years before interview, as well as adjusting for age of initiation of smoking and for various demographic factors.
While the premature termination of the study led to the numbers of cases and controls being substantially less than originally planned, the study still involved a very large number of lung a For the smoking groups, the percentages are of all smokers. For never smokers they are of the total. b All analyses excluded those who had ever smoked cigars or pipes or chewed tobacco, those who had smoked for less than 80% of the critical period of 2e20 years before interview, and those who were mixed smokers throughout the critical period. c The analyses adjusted for more levels of age at interview, education, mean cigarettes smoked 21e50 years ago and mean cigarettes smoked 21e50 years than shown in the FF only" had only ever smoked FF cigarettes in the critical period. "Other" includes smokers in the critical period who had never smoked ULT but smoked LT. e Data were missing on education for 58 cases and 11 controls who smoked and for 4 cases and 16 controls who had never smoked. f Among the smokers, 43 cases and 38 controls had not smoked 21e50 years ago.
cancer cases e over 3500 being considered in the analyses, with almost 250 of the cases having smoked ULT cigarettes in the critical period.
Two main findings emerged from the results. One was that the various adjusted ORs presented were all consistent with some effect of tar reduction in reducing risk of lung cancer. In particular, in the main analysis, those who had smoked ULT for 8 or more years had an estimated risk which was 27% lower than in those who had smoked FF only in the critical period. However, this estimate was not statistically significant, with the 95% CI encompassing a 50% risk reduction to a 6% increase. The wide confidence interval reflects the fact that the number of lung cancer cases studied was less than originally planned, due to the premature termination of the study.
The other main finding was that those who had smoked ULT cigarettes for 8 or more years had a very much higher risk than those who had never smoked, with an OR estimated at 16.27 (95% CI 10.14e26.09). Though, at first glance, these results suggest that ULT cigarettes are still associated with a very high risk of lung cancer, it is important to note that the ULT group in the main analysis consists of individuals who, for much of their smoking life, would have smoked cigarettes with tar levels substantially exceeding 3 mg. Using currently available data it is not possible to compare the lung cancer risk of never smokers with that of lifetime ULT smokers.
A limitation of the study was that the results were not available by histological type, given the argument (e.g. US Surgeon General, 2014) that tar reduction may have caused an increase in the ratio of adenocarcinoma to squamous carcinoma, due to increased inhalation and deposition of particulate matter in the periphery of the lung. While there are no data relating tar level (rather than filter/plain use) to lung cancer type, this claim is dubious for various reasons. These include the lack of evidence of any increased risk of adenocarcinoma in filter compared to plain cigarette smokers (Brooks et al., 2005; Lee et al., 2012; Lee and Sanders, 2004; Marugame et al., 2004; Papadopoulos et al., 2011) , and the evidence of a rise in the ratio of adenocarcinoma to squamous cell carcinoma in nonsmokers and that changes in methods of classifying histological type have contributed to the observed increase in the ratio (Lee and Gosney, 2016) .
Conclusions
Based on a large case-control study involving over 3500 lung cancer cases, the results are consistent with smokers of ULT and LT cigarettes having a somewhat lower risk of lung cancer than smokers of FF cigarettes only. However, premature termination of the study reduced power and most of the odds ratios estimated were not statistically significant. Thus, in the main analysis, smokers with eight or more years of ULT use in the period 2e20 years before diagnosis, had an OR of 0.73 (95%CI 0.50e1.06) compared to smokers of FF only in this period. More data are required to clarify the effects of ULT smoking, particularly of lifetime use.
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